Ann Thorac Surg 2008;86:1174. doi:10.1016/j.athoracsur.2008.07.110
© 2008 The Society of Thoracic Surgeons
Original Articles: Adult Cardiac
Invited Commentary
Song Wan, MD, FRCS
Division of Cardiothoracic Surgery, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, China
(Email: swan@cuhk.edu.hk).
| The first 20% of the full text of this article appears below. |
Aiming to limit blood loss, the recycling of cardiotomy blood shed during open-heart operations with the use of cardiopulmonary bypass (CPB) has been a routine, worldwide practice for the past 5 decades. Nonetheless, the majority of cardiac surgeons recognize that the pericardial blood shed not only contains a mixture of debris, but is also a rich source of activated tissue factors, markers of clotting and fibrinolysis, and pro-inflammatory mediators. Therefore, it has generally been the belief that the intraoperative application of a cell saver could be beneficial in reducing neurologic impairment after CPB (ie, limiting cerebral microemboli) and improving blood conservation through autologous . . . [Full Text of this Article]
Related Article
-
Effects of Shed Mediastinal Blood on Cardiovascular and Pulmonary Function: A Randomized, Double-Blind Study
- Munir Boodhwani, Howard J. Nathan, Thierry G. Mesana, Fraser D. Rubens Cardiotomy Investigators
Ann. Thorac. Surg. 2008 86: 1167-1173.
[Abstract]
[Full Text]
[PDF]
Copyright © 2008 by The Society of Thoracic Surgeons.